{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:16:17Z","timestamp":1788923777506,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.fertnstert.2024.05.154","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T19:02:14Z","timestamp":1716836534000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists"],"prefix":"10.1016","volume":"122","author":[{"given":"Alyse S.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4802-2973","authenticated-orcid":false,"given":"Christina E.","family":"Boots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.05.154_bib1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/AOG.0000000000005202","article-title":"Treatment and management of mental health conditions during pregnancy and postpartum: ACOG clinical practice guideline No. 5","volume":"141","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.fertnstert.2021.08.018","article-title":"Obesity and reproduction: a committee opinion","volume":"116","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10815-012-9826-7","article-title":"Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes","volume":"29","author":"Matorras","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/jc.2013-4086","article-title":"Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women","volume":"99","author":"Shah","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.fertnstert.2018.10.015","article-title":"Effect of class III and class IV obesity on oocyte retrieval complications and outcomes","volume":"111","author":"Romanski","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib6","first-page":"270","article-title":"Impact of class III obesity on outcomes and complications of transvaginal ultrasound-guided oocyte pickup","volume":"1","author":"Liang","year":"2020","journal-title":"F S Rep"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib7","doi-asserted-by":"crossref","first-page":"617.e1","DOI":"10.1016\/j.ajog.2019.05.043","article-title":"The combined impact of maternal age and body mass index on cumulative live birth following in\u00a0vitro fertilization","volume":"221","author":"Goldman","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.fertnstert.2022.07.001","article-title":"Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review","volume":"118","author":"Vitek","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib9","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib10","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa1505297","article-title":"Randomized trial of a lifestyle program in obese infertile women","volume":"374","author":"Mutsaerts","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/humrep\/dex235","article-title":"Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial","volume":"32","author":"Einarsson","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib12","doi-asserted-by":"crossref","first-page":"e3533","DOI":"10.1210\/clinem\/dgab340","article-title":"Effect of orlistat on live birth rate in overweight or obese women undergoing IVF-ET: a randomized clinical trial","volume":"106","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003883","article-title":"Effects of preconception lifestyle intervention in infertile women with obesity: the FIT-PLESE randomized controlled trial","volume":"19","author":"Legro","year":"2022","journal-title":"PLOS Med"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib14","article-title":"A narrative review on effects of maternal bariatric surgery on offspring","volume":"15","author":"Pathak","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155745","article-title":"Bariatric surgery in women with polycystic ovary syndrome","volume":"151","author":"Samarasinghe","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib16","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deac164","article-title":"Outcomes of in-vitro fertilization after bariatric surgery: a national register-based case-control study","volume":"37","author":"Nilsson-Condori","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0043-1776795","article-title":"Navigating the role of anti-obesity agents prior to pregnancy: a narrative review","volume":"41","author":"Goldberg","year":"2023","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13669-023-00350-1","article-title":"Pharmacologic treatment of obesity in reproductive aged women","volume":"12","author":"Nuako","year":"2023","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrneph.2017.123","article-title":"GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes","volume":"13","author":"Muskiet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clnesp.2023.06.015","article-title":"Weight loss trend after bariatric surgery in a population of obese patients","volume":"57","author":"Palumbo","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib29","article-title":"Medication-induced gastroparesis: a case report","volume":"9","author":"Kalas","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00223-023-01150-8","article-title":"Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone\u00a0health in people living with obesity","volume":"114","author":"Herrou","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MED.0000000000000835","article-title":"Glucagon-like peptide-1 receptor agonists and safety in the preconception period","volume":"30","author":"Minis","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijgo.15092","article-title":"Semaglutide and pregnancy","volume":"163","author":"Skov","year":"2023","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib34","author":"Joshi"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib35","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib36","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the\u00a0STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jogc.2020.09.023","article-title":"The relationship between pre-pregnancy attempts to lose weight and gestational weight gain: an exploratory primary care prospective cohort study","volume":"43","author":"Piccinini-Vallis","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib38","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib39","first-page":"RC10.3","article-title":"The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: a 2-year observational study","volume":"90","author":"Jensterle","year":"2023","journal-title":"Endocr Abstr"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humupd\/dmz019","article-title":"The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective","volume":"25","author":"Jensterle","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.05.154_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study","volume":"179","author":"Salamun","year":"2018","journal-title":"Eur J Endocrinol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224004709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224004709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T01:09:50Z","timestamp":1754010590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224004709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0015028224004709"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.05.154","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.05.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}